Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 0 | 0 | 17,344 |
| Other current assets | 38,423 | 0 | 0 | 49,927 | 87 |
| TOTAL | $38,423 | $N/A | $0 | $49,927 | $17,431 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,395 | 0 | 0 | 1,130 | 823 |
| TOTAL | $1,395 | $N/A | $N/A | $1,130 | $823 |
| Total Assets | $39,818 | $N/A | $0 | $51,057 | $18,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | N/A | N/A | 0 | 1,426 | 1,564 |
| Other current liabilities | N/A | N/A | 0 | N/A | 71 |
| TOTAL | $N/A | $N/A | $0 | $1,426 | $1,635 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 31,806 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $31,806 |
| Total Liabilities | $4,649 | $N/A | $0 | $1,426 | $33,441 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 0 | N/A | 1 |
| Retained earnings | N/A | N/A | 0 | 0 | -27,223 |
| Other shareholders' equity | 35,169 | 0 | 0 | 49,631 | -196 |
| TOTAL | $35,169 | $N/A | $0 | $49,631 | $-15,093 |
| Total Liabilities And Equity | $39,818 | $0 | $0 | $51,057 | $18,348 |